Condition: Intracerebral Haemorrhage · Sponsor: Aarhus University Hospital
Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP \<140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, and healthcare resource utilization.
This description comes directly from the study's public registry record.
Rolf Blauenfeldt, MD, PhD · +4520774053 · rolfblau@rm.dk
Claus Z Simonsen, MD, PhD · clausimo@rm.dk
Always discuss trial participation with your own doctor first.
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07044232